CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
Titel:
CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
Auteur:
Gao, Jennifer J Cheng, Joyce Bloomquist, Erik Sanchez, Jacquelyn Wedam, Suparna B Singh, Harpreet Amiri-Kordestani, Laleh Ibrahim, Amna Sridhara, Rajeshwari Goldberg, Kirsten B Theoret, Marc R Kluetz, Paul G Blumenthal, Gideon M Pazdur, Richard Beaver, Julia A Prowell, Tatiana M